Target intelligence / Profile preview

Tubulin tyrosine ligase-like protein 10 (TTLL10)

Target
TTLL10
Molecular classification
Enzyme, Ligase (specifically, protein-glycine ligase/polyglycylase)
01

Overview

TTLL10 encodes an enzyme responsible for elongating polyglycine chains on already monoglycylated substrates. Unlike TTLL8, which initiates monoglycylation, TTLL10 only adds additional glycine residues to those branches, in both α- and β-tubulin tails, and also modifies NAP1, particularly in spermatids. TTLL10 activity requires pre-existing monoglycylation, is enhanced by tubulin glutamylation, and self-limits its association with microtubules as chain length increases. TTLL10 is expressed predominantly in testis (mouse), with possible roles in gametogenesis through NAP1 modification. TTLL10 is not an established drug target and has no known interacting drugs. Its activity contributes to post-translational modification patterns required for microtubule and chromatin function. Key distinctions: TTLL10 should not be confused with TTLL5, which is a separate enzyme in the same family. TTLL10 is not a therapeutic target nor is it associated with clinical biomarker or pharmacological safety data.

Other names
Inactive polyglycylase TTLL10FLJ36119TTLL10Tubulin--tyrosine ligase-like protein 10
02

Mechanism of action

Not applicable. There are no drugs targeting TTLL10 described in the literature.

03

Biological functions

Protein polyglycylation (addition of glycine chains)Post-translational modification of tubulin and NAP1Regulation of cilia structure/function (through tubulin modification)Potential role in chromatin remodeling during spermiogenesis (via NAP1 modification)
04

Disease associations

Other; no well-established disease correlationsPotential contribution to ciliary dysfunction and infertility (mouse testis expression) due to defects in tubulin modifications
05

Biomarkers

None reported; modification patterns of tubulin (glycylation/polyglycylation) could be theoretically detectable but are not clinical biomarkers.

Beyond the preview

Go deeper on Tubulin tyrosine ligase-like protein 10 (TTLL10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin tyrosine ligase-like protein 10 (TTLL10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call